Iodine UL: 1,100 mcg/day (Thyroid Dysfunction Risk)

For adults, the iodine UL is 1,100 mcg/day (FDA DRI). Excess iodine can disrupt thyroid function, causing both hypo- and hyperthyroid patterns depending on underlying disease. Kelp supplements are notoriously variable in iodine content, making them a frequent audit target for thyroid risk. Iodine ULs exist because autonomous thyroid tissue and pregnancy change the margin of safety; kelp products vary in potency batch to batch. Combining thyroid support blends with iodized diet components and multivitamins can approach risky totals without obvious symptoms until thyroid labs shift. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Long-term supplement habits deserve periodic review the same way medications do: indications change, kidney function changes, diets change, and goals change. A seasonal vitamin D strategy at higher latitude differs from year-round megadosing without 25(OH)D monitoring. Iron repletion should have an endpoint informed by ferritin and symptoms, not infinite pills because fatigue persisted for unrelated reasons. Protein powders displace whole-food meals for some busy users, creating micronutrient gaps that another capsule cannot honestly fix. If a supplement has not produced a measurable or symptomatic benefit after a reasonable trial window, reconsider the diagnosis and the product rather than adding compensatory layers. FDA Dietary Reference Intakes publish Recommended Dietary Allowances and Tolerable Upper Intake Levels so consumers and clinicians can compare habitual intake to evidence-based safety envelopes. Those numbers assume you add every relevant source in a day: tablets, capsules, powders, functional beverages, and sometimes fortified foods that repeat the same nutrient under unfamiliar names. When two products both say “immune support” but one lists ascorbic acid and another lists mineral ascorbates, your audit still has to treat them as the same vitamin C ledger entry. The same aggregation rule applies to retinol esters, multiple forms of magnesium salts, and duplicate B vitamins across energy products. NutriAudit’s overlap engine is designed to mirror that regulatory mindset: totals first, brand stories second. If your summed intake approaches or exceeds a UL, the next step is clinician review, not another retail product to “balance” the stack without labs. Gut health hype popularizes probiotics, prebiotics, digestive enzymes, and fiber powders simultaneously, sometimes provoking bloating instead of relief. Post-antibiotic probiotic timing is debated; immunocompromised hosts face infection risk from live cultures; SIBO presentations worsen for some with certain strains. Pancreatic insufficiency and celiac disease require medical enzyme and diet strategies, not guesswork stacks. Acid suppression changes upper GI flora and nutrient extraction. If diarrhea is bloody, febrile, or severe, stop experimenting and seek urgent care rather than doubling probiotic CFUs. Cost and pill burden influence adherence: elaborate twelve-product stacks often collapse into inconsistent use, creating irregular peaks and troughs that confuse both benefits and side effects. Consolidating to fewer, purpose-driven products under clinician guidance usually beats additive complexity. Subscription boxes and influencer bundles introduce new ingredients monthly, making causality impossible to track. A simple spreadsheet or NutriAudit export beats memory when you need to answer “what changed before this symptom started?” Keep start and stop dates whenever you add or remove a bottle. Bleeding risk is one of the most common supplement–drug interaction themes because patients combine fish oil, high-dose vitamin E, turmeric/curcumin, garlic concentrates, ginkgo, and NSAIDs without summing antiplatelet burden. Sedation stacks layer melatonin, valerian, antihistamines, alcohol, and prescription sleep aids until morning impairment and fall risk rise, especially in older adults. Serotonergic stacking can occur when St John’s wort or high-dose tryptophan-adjacent products overlap SSRIs, SNRIs, MAOIs, or triptans. These are not “maybe someday” interactions; they are emergency-department patterns when disclosure fails. Your written stack list should include doses, brands, and start dates so clinicians can interpret symptoms temporally. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.